A new Ph1+, bcr cell line derived from a patient with ALL-L1 gained autonomy in culture concomitant to CD23 expression.
A permanent cell line, LEF1, has been established from the cells of an adult suffering from a Philadelphia positive acute lymphoblastic leukemia. The LEF1 cell line was obtained by maintaining peripheral blood cells from the patient in culture on a fibroblast feeder; subsequently, an autonomously growing cell population, independent of that feeder layer, developed. The karyotype of the cell line, 46, t(9;22)(q34;q11), was different from the karyotype at diagnosis which had 53 chromosomes and two Philadelphia chromosomes. Furthermore, compared with the initial leukemic blasts, the immortalized cell had three differences in surface phenotype (CD23+, CD11b-, CD10-). However, molecular studies indicated that the breakpoint in the 3' part of the first intron of the BCR gene was unchanged, confirming the leukemic origin of LEF1. The cell line was shown to be Epstein-Barr virus negative.
Grausz
D
D
INSERM U301, and SDI No. 15954 CNRS, Paris, France.
Lanotte
M
M
Valensi
F
F
Hillion
J
J
Chen
S J
SJ
Chen
Z
Z
Morinet
F
F
Berger
R
R
D000328:Adult; D015703:Antigens, CD / Q000032:analysis; D000944:Antigens, Differentiation, B-Lymphocyte / Q000032:analysis*; D015152:Blotting, Northern; D015139:Blotting, Southern; D002455:Cell Division; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D009857:Oncogenes; D010641:Phenotype; D010677:Philadelphia Chromosome; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics* / Q000276:immunology / Q000473:pathology; D011961:Receptors, Fc / Q000032:analysis*; D017455:Receptors, IgE; D015183:Restriction Mapping; D014407:Tumor Cells, Cultured / Q000276:immunology / Q000473:pathology
D015703:Antigens, CD; D000944:Antigens, Differentiation, B-Lymphocyte; D011961:Receptors, Fc; D017455:Receptors, IgE